Project Grant R01HD113989
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $320,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Marshfield Clinic, Inc. The project aims to identify genomic regulatory elements involved in the development of oral clefts, a common birth defect. Specifically, the research will 1) identify enhancers that drive gene expression in human embryonic palatal mesenchyme cells, 2) determine which enhancers regulate transcription...
- This $645,034 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, supports a research project titled "LEVERAGING WHOLE GENOME SEQUENCING AND FUNCTIONAL GENOMIC CHARACTERIZATION TO IMPROVE NSCLP GENE DISCOVERY." The project aims to integrate genomic data, including whole genome sequencing and polygenic risk scores, to systematically evaluate and validate the contributions of...
- The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,281,274 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute. The grant, titled "Leveraging Advances in Practices and Outcomes in Cleft Care: The LEAP Study", aims to create an inclusive global collaborative to develop a cleft-focused learning health system. The project will focus on the...
- This federal Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a $161,644 multifaceted investigation into speech outcomes following maxillary advancement surgery for individuals with cleft palate. The 5-year study, beginning on July 1, 2025, aims to: 1) investigate anatomical risk factors for post-operative velopharyngeal insufficiency, 2) quantify the relationship...
- This federal Project Grant award of $129,420.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant supports research conducted by The Leland Stanford Junior University (Stanford University) to investigate methods for improved cleft palate bone regeneration. The key objectives of the research are to: 1) Identify how differences in skeletal stem cell subpopulations and receptor usage...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $187,500 Project Grant on August 11, 2025 to the Pennington Biomedical Research Center in Louisiana. The grant, titled "BEYOND FOLATE - A SUPPLEMENTATION STRATEGY TO PREVENT NEURAL TUBE DEFECTS", falls under the NICHD's Child Health and Human Development Extramural Research program (CFDA 93.865). The project aims to investigate a novel nutritional approach to prevent neural tube...
- This federal Project Grant award of $1,608,956.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR), which administers the Oral Diseases and Disorders Research program (CFDA 93.121). The grant aims to generate a single-cell multimodal atlas of human craniofacial development and conduct evolution-driven computational and experimental studies of enhancers involved in human midface development. This research is intended to improve understanding of the genetic...
- This Project Grant award of $474,878 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to quantify the impact of hyperglycemia on embryonic metabolism and development in C. elegans. The key objective of this 2-year project is to generate single-cell resolution data on how cellular metabolism changes over the course of embryonic development in normal and...
- This $295,856 Project Grant awarded by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), aims to identify rare genetic variants associated with orofacial clefts (OFCs). The two key objectives are: (1) identifying craniofacial genes with rare deleterious variants, and (2) identifying craniofacial enhancers with rare deleterious variants. By pinpointing these rare variants, the project seeks to...
- This Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR), supports research under the Oral Diseases and Disorders Research program (CFDA 93.121) on the role of primary cilia and the C2CD3 protein in craniofacial skeletal development. The $646,212 award to the Children's Hospital Medical Center in Cincinnati, Ohio will fund experiments to determine if skeletal differentiation is impaired in human induced pluripotent stem cell-derived neural crest...
IMPACT OF MATERNAL DIETARY VITAMIN A ON RISK AND SEVERITY OF CLEFT LIP/PALATE IN GENETICALLY SENSITIZED EMBRYOS - PROJECT SUMMARY THE TERM "CLEFT LIP WITH OR WITHOUT CLEFT PALATE (CL/P)" ENCOMPASSES A VARIETY OF CLINICAL PRESENTATIONS THAT COLLECTIVELY REPRESENT ONE OF THE MOST COMMON HUMAN BIRTH DEFECTS. FOR EACH PATIENT, THE IMPACT CAN ALSO BE SIGNIFICANT. THE SEVERITY OF A PATIENT'S CLINICAL PRESENTATION IS THE MAJOR DETERMINANT OF THE DURATION AND FREQUENCY OF SIGNIFICANT SURGICAL INTERVENTION AND LONG-TERM CLINICAL CARE. CONSIDERABLE PROGRESS HAS BEEN MADE OVER THE LAST FEW DECADES TO DETERMINE THE GENES RESPONSIBLE FOR SYNDROMIC FORMS OF CL/P. HOWEVER, THE LOW PENETRANCE AND VARIABILITY IN PRESENTATION POSE CHALLENGES WHEN COUNSELING FAMILIES ABOUT RECURRENCE RISKS, AS IT IS CURRENTLY IMPOSSIBLE TO PREDICT WHETHER A CHILD WILL BE BORN WITH CL/P OR HOW SEVERE THE PRESENTATION MIGHT BE REGARDLESS OF WHETHER A GENETIC PREDISPOSITION IS KNOWN. THIS NEW PROPOSAL BUILDS ON IMPORTANT NEW OBSERVATIONS AND EXCITING PRELIMINARY DATA ON ESTABLISHED MOUSE MODELS OF CL/P TO BEGIN TO DISSECT THE FACTORS THAT INFLUENCE THE CLEFT PENETRANCE AND SEVERITY IN EMBRYOS THAT ARE GENETICALLY PREDISPOSED TO CL/P. SPECIFICALLY, THIS PROJECT WILL ADDRESS THE ROLE OF MATERNAL DIET (SPECIFICALLY VITAMIN A) AS A MODIFIER OF GENETIC SUSCEPTIBILITY, SEVERITY OF PRESENTATION AND IN UTERO CORRECTION PRIOR TO BIRTH, AS WELL AS INVESTIGATE THE BASIS FOR THE LEFT BIAS IN UNILATERAL CLEFT PRESENTATIONS. ALTHOUGH VITAMIN A AND ITS DERIVATIVES HAVE LONG BEEN IMPLICATED AS A RISK FACTOR IN CL/P, THIS PROJECT WILL EXPLOIT A NOVEL MOUSE MUTANT BACKGROUND THAT OVERCOMES THE LIMITATIONS OF PRIOR ANIMAL MODEL STUDIES SUCH AS THE NEED FOR EXCESSIVE, NON-PHYSIOLOGIC LEVELS OF VITAMIN A AND UNNATURAL ROUTES OF ADMINISTRATION. FURTHERMORE, WE TEST THE IMPACT ON TWO DISTINCT UNDERLYING GENETIC SUSCEPTIBILITIES. THE SUCCESSFUL DEMONSTRATION OF MODIFYING ROLES FOR THESE FACTORS COULD ULTIMATELY HAVE A SIGNIFICANT IMPACT ON PATIENT COUNSELLING AND POTENTIALLY OPEN UP THE POSSIBILITY OF DEVELOPING SIMPLE AND EFFECTIVE INTERVENTIONAL AND PREVENTATIVE MATERNAL DIETARY INTERVENTIONS SUCH AS PERSONALIZED DIETARY SUPPLEMENTATION FOR MOTHERS CARRYING CL/P RISK ALLELES, OR CROP BIOFORTIFICATION APPROACHES FOR WHOLE POPULATIONS WHERE DIETARY DEFICIENCIES AND GENETIC RISK FACTORS ARE KNOWN. SUCH APPROACHES COULD HAVE A PROFOUND IMPACT ON THE INCIDENCE OF NS-CL/P, MUCH LIKE THE SUCCESSES SEEN FOR MATERNAL FOLIC ACID SUPPLEMENTATION FOR REDUCING THE RISK OF NEURAL TUBE DEFECTS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $336.5k | 4/14/25 | ||
| Not listed | $336.5k | 8/2/24 | ||
| Not listed | $336.5k | 8/2/24 |